Your Location：
Home >
Browse articles >
Treatment of Myocardial Injury from Coronavirus Disease-2019 by Chinese Medicine
Topic on Epidemic Resistance | Updated：2020-09-16
Previous|Next

    • Treatment of Myocardial Injury from Coronavirus Disease-2019 by Chinese Medicine

    • SHEN Li , TANG Dan-li , CAO Hong-xin
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 19, Pages: 80-83(2020)

    • DOI： 10.13422/j.cnki.syfjx.20201926     

      CLC：

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

51

Views

53

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Exploring Potential Biomarkers of Blood Stasis Syndrome in Coronary Heart Disease and Association Between Platelet Metabolic Disorder and Myocardial Injury Based on Platelet Metabolomics
Quansanqi Tablets Ameliorate Myocardial Injury via MAPK and NF-κB Signaling Pathway
Underlying Mechanisms of Huashi Baidu Prescription Against Myocardial Injury Based on "Transcriptome-Putative Target-Phenotype Gene" Interactions
Mechanism of Ferroptosis in Myocardial Cells and Protective Effect of Traditional Chinese Medicine
Immunomodulatory Mechanism of Kangxian Yixin Prescriptions on Autoimmune Injury Mice Based on Th17/Treg Cell Balance

Related Author

ZHAO Yanzhen
BAI Siyang
JIAN Weixiong
ZHOU Manli
ZHONG Chengzhi
GONG Lyudong
LI Ting
YAN Hong

Related Institution

Hunan Provincial Key Laboratory of Traditional Chinese Medicine Diagnostics，College of Chinese Medicine，Hunan University of Chinese Medicine
Yunnan Province Company Key Laboratory for Traditional Chinese Medicine and Ethnic Drug of New Drug Creation， Yunnan Institute of Materia Medica
Yunnan Baiyao Group Co. Ltd.
NMPA Key Laboratory for Research and Evaluation of Traditional Chinese Medicine
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences